Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of St. Jude Medical Inc (NYSE: STJ) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of St. Jude Medical Inc (NYSE: STJ) concerning whether a series of statements by St. Jude Medical Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 11, 2016, St. Jude delivered a letter to physicians and patients warning that batteries on thousands of the Company's implantable defibrillators can rapidly and without warning deplete.  St. Jude revealed that two people had died after their devices failed to work correctly because of the drained battery, while 47 others reported dizziness or fainting.  The devices are in use by approximately 350,000 individuals. The warning applies to devices made before May 2015.

Following this news, NYSE: STJ has declined as much as $2.76, or 3.4%, during intraday trading on October 11, 2016.

Based in St. Paul, Minnesota, and founded in 1976 St. Jude Medical Inc develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas globally.

If you purchased shares of St. Jude Medical Inc (NYSE: STJ) on or before October 11, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185